precisionlife

PrecisionLife is a radical new approach to the analysis of complex diseases based on patients' genomic and clinical data. Using our powerful multi-omics analysis platform to screen genomic, phenotypic, and patient health datasets, we provide unique insights into the characteristics driving complex diseases. Rapidly identify new targets, biomarkers, and drug candidates, leading to the discovery and delivery of precision medicines. These disease characteristics have been shown to guide us towards validated targets, drug discovery opportunities, and better personalized medicines. Headquartered in Oxford, UK, with new offices in Copenhagen, Massachusetts, Warsaw, and Boston, we were founded by a diverse team of experienced leaders from life sciences, healthcare, artificial intelligence, and computer science.